Earlier heat maps
Heat map presentations
The following heat maps are available:
The maps below are heat maps which were updated in January 2018
The maps below are heat maps which were updated in October 2017
The maps below are heat maps which were updated in July 2017
The maps below are heat maps which were updated in April 2017
The maps below are heat maps which were updated in January 2017
The maps below are heat maps which were updated in October 2016
The maps below are heat maps which were updated in July 2016
- Primary Medicines at CCG level
- Grouped Medicines at CCG level
- Medical Technologies at CCG level
- Diagnostics at CCG level
The maps below are heat maps which were updated in May 2016
- Grouped Medicines at CCG level
- Primary Medicines at CCG level
- Medical Technologies at CCG level
- Diagnostics at CCG level
The maps below are heat maps which were updated in January 2016
- Medicine Groupings
- Primary Medicines at CCG level
- Medical Technology at CCG level
- Diagnostics at CCG level
The maps below are heat maps which were updated in October 2015
- Key Primary Medicines at CCG level
- Key Secondary Care Medicines at regional level
- Medical Technology at CCG level
- Medical Technology at Area Team level
The maps below are heat maps which were updated in May 2015
- Key Primary Medicines at CCG level
- Key Secondary Care Medicines at regional level
- Medical Technology at CCG level
- Medical Technology at Area Team level
The maps below are heat maps which were updated in January 2015
- Key Primary Medicines at CCG level
- Key Secondary Care Medicines at regional level
- Medical Technology at CCG level
- Medical Technology at area team level
The maps below are heat maps which were updated in October 2014
- Heat maps on the use of some key primary care medicines and how these have changed over the last year on a quarterly basis at CCG level.
- Heat maps on the use of some key secondary care medicines and how these have changed over the last year on a quarterly basis.
- Heat maps on the use of Medical Technologies (HES).
A heat map at Area Team level for Q2 2010-11 to Q3 2012-13 for spend on Denosumab for Prevention of osteoporotic fractures in women aged 50 or over , based upon Use of NICE appraised medicines in the NHS in England – 2012, experimental statistics.
Heat maps at area team level on the ratio of use to expected use of:
- Ranibizumab for macular degeneration
- Trastuzumab for breast cancer and gastric cancer.
based upon Innovation Scorecard Table 1.2 March 2014
Heat maps at CCG level showing relative use of medical technologies for the period October 2012 – September 2013 based upon Hospital Episode Statistics and CCG Registered Populations for October 2013. Revised data is now available for Hospital Episode Statistics and CCG Registered Populations for January to December 2013.
A spreadsheet containing the underlying data for this can be accessed below:
- 2014-02-26 Medical Technologies per 100k population table
- 2014-6-12 Pub Table 2.2 Medical Technologies
Heat maps at NHS Trust Level on spend for 64 medicines purchased between April and September 2013 based upon Innovation Scorecard Table 3.1 March 2014. Revised data is now available for April to December 2013.
Heat maps for the high profile medicines in the innovation scorecard Table 5
Medicines in Table 5 are used across primary and secondary care settings, so heat maps from different settings need to be considered together. The following atlases have been produced.
- An Area Team Level atlas on spend per 100,000 Resident population for April and September 2013 (December data are not currently available). This is based upon Innovation Scorecard Table 5.2.
- A CCG Level. Defined Daily Doses per 100,000 CCG Registered populations atlas for April to December 2013
- Supporting spreadsheet: 2014-6-12 Pub Table 5 Medicines CCG Level Apr-Dec 2013
- An NHS Trust Level mg purchased per 100,000 days of care atlas for April and December 2013
- Supporting spreadsheet: 2014-06-12 Pub Table 5 Medicines Trust Level Data Apr-Dec 2013